Simvastatin Therapy in Women With Polycystic Ovary Syndrome.
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether statins (simvastatin) improve clinical
(excessive hair, skin problems), endocrine (androgens) and metabolic (lipids, markers of
systemic inflammation) in women with polycystic ovary syndrome (PCOS).